RE: RE: Insider Sales - QuestionsNot sure Peter Milner has any relevance here?
CALGARY, ALBERTA, May 19, 2010 (MARKETWIRE via COMTEX News Network) --
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE: SSS) reports that the following matters were put to a vote at the Annual General Meeting (AGM) and the report on voting results is as follows:
1. Election of Directors
The number of directors set at seven and the following individuals were elected as directors of the Corporation to hold office until their successors are elected at the next annual meeting of the Corporation:
Ian Brown
James DeMesa
Peter Milner
Alan Moore
Robert Rieder
Scott Tannas
Mark Wayne
All of the above individuals were incumbents with the exception of Dr. Peter Milner. Dr. Milner is a board certified physician and cardiologist, and serves as voluntary clinical faculty at Stanford Veterans' Hospital. In June 1992, Dr. Milner co-founded CV Therapeutics, Inc., a biopharmaceutical company. Prior to CV Therapeutics, Inc., Dr. Milner was an assistant professor of medicine at Washington University in St. Louis, Missouri. Dr. Milner has numerous patents in his name and is the author of several scientific articles published in peer-reviewed journals. Dr. Milner attended the University of Liverpool, England where he received a bachelor of sciences degree with honors in biochemistry and a degree in medicine. He completed his postgraduate training in medicine at Johns Hopkins Medical School, cardiology and pharmacology at University of Virginia and molecular biology at Washington University in St. Louis. Dr. Milner is a Fellow of the American College of Cardiology, serves on the board of directors of California Healthcare Institute and the Scientific Advisory Board of Novartis Institute of Biomedical Research in Cambridge, Massachusetts.